李斌,孔宁
LI Bin,KONG Ning

• 1:广州市番禺区中心医院眼科

摘要(Abstract)：

目的观察玻璃酸钠联合普拉洛芬对苯扎氯铵诱导新西兰兔干眼的治疗作用。方法使用0.25%苯扎氯铵滴眼液复制新西兰兔干眼模型,选择75只制作成功的动物模型随机分为3组。A组为空白对照组,不做任何处理;B组为单纯玻璃酸钠组,给予0.1%玻璃酸钠滴眼液,每天4次;C组为玻璃酸钠联合普拉洛芬组,给予0.1%玻璃酸钠滴眼液+普拉洛芬滴眼液,每天4次。观察D0、D3、D7、D14时的角膜荧光染色评分、泪膜破裂时间、泪液分泌等指标并进行统计分析。结果干预前各组间荧光染色评分、泪膜破裂时间、泪液分泌结果差异无统计学意义(P>0.05),具有可比性;干预后第7天及第14天,B组及C组各项观察指标均优于A组(P<0.05);C组较B组改善更为明显,差异有统计学意义(P<0.05)。结论玻璃酸钠联合普拉洛芬可以有效改善苯扎氯铵导致的新西兰兔的干眼症状。
To observe the effect of sodium hyaluronate combined with Pranoprofen on the dry eye in New Zealand rabbits induced by topical medication of Benzalkonium Chloride. METHODS New Zealand rabbits were treated with 0. 25%benzalkonium chloride to establish dry eye model. Seventy-five New Zealand rabbits were randomly divided into 3 groups: A group was control group without any treatment; B group were treated with 0.1% Sodium Hyaluronate eye drops; C group were treated with 0.1%Sodium Hyaluronate eye drops combined with Pranoprofen eye drops,four times per day. Corneal fluorescein staining scores,tear break up time and tear secretion were evaluated in each group on D0,D3,D7 and D14. RESULTS At baseline the difference between each group of corneal fluorescein staining scores,tear break up time and tear secretion was not statistically significant( P>0.05). On D7 and D14,in B group and C group,all the indexes were better than those in group A( P< 0.05). In addition,the indexes in C group were better than those in B group( P<0.05). CONCLUSION The sodium hyaluronate combined with pranoprofen can effectively improve dry eye induced by topical medication of Benzalkonium Chloride.

关键词(KeyWords)： 玻璃酸钠;普拉洛芬;苯扎氯铵;干眼;新西兰兔
sodium hyaluronate;pranoprofen;benzalkonium chloride;New Zealand rabbit;dry eye

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李斌,孔宁
LI Bin,KONG Ning

参考文献(References)：

• [1]袁进,陈家祺.加强和规范干眼的临床研究[J].眼科,2010,19(3):148-149,154.
• [2]中华医学会眼科学分会角膜病学组.干眼临床诊疗专家共识(2013年)[J].中华眼科杂志,2013,49(1):73-75.
• [3]毛真,刘杏,钟毅敏,等.毛果芸香碱和布林佐胺滴眼液对兔眼表组织的影响[J].中国病理生理杂志,2008,24(11):2251-2256.
• [4]王双勇,田英,程燕,等.不同浓度玻璃酸钠对新西兰兔干眼眼表变化的影响[J].国际眼科杂志,2015,15(10):1705-1708.
• [5]Pauly A,Brignole-Baudouin F,Labbe A,et al.New tools for the evaluation of toxic ocular surface changes in the rat[J].Invest Ophthalmol Vis Sci,2007,48(12):5473-5483.
• [6]李宁,陈松,陈彦纯,等.聚季铵盐-1和苯扎氯铵在眼用制剂中的应用研究进展[J].今日药学,2015,25(2):140-143.
• [7]Freeman P D,Kahook M Y.Preservatives in Topical Ophthalmic Medications:Historical and Clinical Perspectives[J].Expert Rev Ophthalmol,2009,4(1):59-64.
• [8]Ishibashi T,Yokoi N,Kinoshita S.Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride[J].J Glaucoma,2003,12(6):486-490.
• [9]Brasnu E,Brignole-Baudouin F,Riancho L,et al.In vitro effects of preservative-free tafluprost and preserved latanoprost,travoprost,and bimatoprost in a conjunctival epithelial cell line[J].Curr Eye Res,2008,33(4):303-312.
• [10]Aragona P,Tripodi G,Spinella R,et al.The effects of the topical administration of non-steroidal anti-inflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects[J].Eye,2000,14(2):206-210.
• [11]薛红权.重组牛碱性成纤维细胞生长因子滴眼液联合玻璃酸钠滴眼液治疗干眼症的疗效观察[J].医学理论与实践,2016,29(20):3513-3514.
• [12]Rossi Paccani S,Boncristiano M,Baldari CT.Molecular mechanisms underlying suppression of lymphocyte responses by nonsteroidalantiinflammatory drugs[J].Cell Mol Life Sci,2003,60(6):1071-1083.
• [13]毛蕾,刘春兰,周琼.双氯芬酸钠滴眼液联合玻璃酸钠滴眼液治疗干眼症的疗效[J].实用临床医学,2016,17(1):51-52.
• [14]刘明,陈珺.普拉洛芬滴眼液不同用药时间对干眼症疗效的影响[J].眼科新进展,2016,36(10):946-948.
• [15]梅淑萍.非甾体抗炎滴眼液的不良反应观察[J].中国实用医药,2013,8(14):28-29.